CoChat

Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study

Morgia, G., Mucciardi, G., Galì, A., Madonia, M., Marchese, F., Di Benedetto, A., Romano, G., Bonvissuto, G., Castelli, T., Macchione, L., Magno, C. · 2010 · Urologia Internationalis
Cited by 49

The DOI matches its Crossref record, with a small difference in title or year.

Abstract

Objectives: To evaluate the efficacy and safety of Serenoa repens + selenium and lycopene (Profluss®) versus S. repens alone for the treatment of category IIIa chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Patients and Methods: 102 patients with IIIa CP/CPPS were enrolled and randomized into two groups each to receive Profluss or S. repens alone for 8 weeks. Evaluation was based on results of the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), IPSS, maximum peak flow rate (MPFR), and PSA measurements at baseline and at weeks 4, 8 and 8 after the end of treatment. The primary endpoint was a >50% reduction in NIH-CPSI score. Secondary endpoints evaluated were MPFR, IPSS, PSA and white blood cell count. Results: No patients withdrew from the study. The mean NIH-CPSI score decreased significantly (p < 0.001) in both groups; we observed a decrease in the total score from 27.45 to 13.27 in group 1 (–51.64%) and from 27.76 to 20.62 in group 2 (–26.06%). IPSS improved significantly (p < 0.001) in both arms, but more in group 1. PSA and white blood cell count decreased significantly (p < 0.007) only in group 1. The MPFR improved more in group 1 (p < 0.005). Conclusion: Profluss is a triple therapy that is safe and well tolerated. It ameliorates symptoms associated with IIIa CP/CPPS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000302716

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. 10.1111%2Fj.1464-410X.2005.05341.x · DOI
  2. 10.1016%2FS0090-4295%2898%2900034-X · DOI · Paper page
  3. 10.1046%2Fj.1464-410X.2000.00836.x · DOI · Paper page
  4. 10.1016%2FS0022-5347%2805%2965301-3 · DOI · Paper page
  5. 10.1001%2Fjama.282.3.236 · DOI · Paper page
  6. 10.1146%2Fannurev.med.57.011205.135654 · doi:10.1146/annurev.med.57.011205.135654
  7. 10.1016%2FS0022-5347%2801%2966359-6 · DOI · Paper page
  8. 10.1111%2Fj.1525-1497.2001.01223.x · DOI · Paper page
  9. 10.1001%2Farchinte.164.11.1231 · DOI
  10. 10.1016%2FS0022-5347%2805%2968562-X · DOI · Paper page
  11. 10.1016%2FS0094-0143%2805%2970215-9 · doi:10.1016/s0094-0143(05)70215-9
  12. 10.1016%2Fj.urology.2003.11.002 · DOI
  13. 10.1016%2Fj.mehy.2004.11.039 · doi:10.1016/j.mehy.2004.11.039
  14. 10.1517%2F14796694.1.3.425 · DOI
  15. 10.1188%2F06.ONF.127-137 · DOI
  16. 10.1016%2Fj.abb.2004.04.023 · DOI · Paper page
  17. 10.1016%2Fj.ejpain.2007.10.008 · DOI
  18. 10.1016%2Fj.gassur.2005.08.035 · DOI
  19. 10.1016%2Fj.pbb.2006.02.002 · doi:10.1016/j.pbb.2006.02.002
  20. 10.1111%2Fj.1464-410X.2003.04735.x · doi:10.1111/j.1464-410x.2003.04735.x
  21. 10.1016%2F0960-0760%2895%2900134-L · DOI
  22. 10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C232%3A%3AAID-PROS4%3E3.0.CO%3B2-0 · doi:10.1002/(sici)1097-0045(19990901)40:4<232::aid-pros4>3.0.co;2-0
  23. 10.1002%2F%28SICI%291097-0045%2819981001%2937%3A2%3C77%3A%3AAID-PROS3%3E3.0.CO%3B2-I · DOI
  24. 10.1159%2F000019570 · DOI
  25. 10.1016%2FS0952-3278%2897%2990548-2 · DOI
  26. 10.1097%2F01.ju.0000101487.83730.80 · DOI · Paper page
  27. 10.1093%2Fecam%2Fneh128 · doi:10.1093/ecam/neh128
  28. 10.1016%2Fj.ijantimicag.2007.07.016 · doi:10.1016/j.ijantimicag.2007.07.016
  29. 10.1002%2Fmnfr.200700346 · DOI · Paper page
  30. 10.1097%2F00001648-200007000-00007 · DOI

Cited by

See all 49

Metadata

Authors
Morgia, G., Mucciardi, G., Galì, A., Madonia, M., Marchese, F., Di Benedetto, A., Romano, G., Bonvissuto, G., Castelli, T., Macchione, L., & Magno, C.
Venue
Urologia Internationalis
Publisher
S. Karger AG
Published
2010
Volume
84
Issue
4
Pages
400-406
ISSN
  • 0042-1138
  • 1423-0399
Cited by
49
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study. https://app.cochat.ai/papers/10.1159/000302716
The paper
Morgia, G., Mucciardi, G., Galì, A., Madonia, M., Marchese, F., Di Benedetto, A., Romano, G., Bonvissuto, G., Castelli, T., Macchione, L., & Magno, C. (2010). Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study. Urologia Internationalis. https://doi.org/10.1159/000302716

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.